Table 1 Patient characteristics
Patient ID | Sex | Age (Years) | PS (ECOG) | HLA | Site of Evaluable Disease | Pretreatments |
|---|---|---|---|---|---|---|
1 L.A. | M | 75 | 1 | A2A32Cw4Cw6 | spleen, soft tissue | IFN |
2 G.I. | F | 66 | 0 | A24A11B44B18Bw4Bw6Cw5Cw7 | pelvis | CT+RT |
3 M.G. | M | 73 | 1 | A1A10B13B41Bw4Bw6 | liver, lymph node | CT |
4 S.P. | M | 56 | 1 | A9A32B38B55Bw4Bw6Cw3 | lung, bone, lymph node | BIOCT |
5 G.C. | M | 51 | 0 | A1A2B8B35Bw6Cw4Cw7 | liver, lymph node | IFN |
6 Z.V. | M | 42 | 1 | A1A19B51B14 | lung | BIOCT |
7 G.L. | M | 56 | 2 | A3A28B35B53Cw4 | liver | BIOCT |
8 B.A. | M | 35 | 2 | A2A9B7B15Bw6Cw3Cw7 | lung, bone skin | BIOCT |
9 P.M. | M | 45 | 0 | A1A9B17Bw4Bw6Cw3Cw4 | lung, lymph node | BIO, BIOCT |
10 P.M. | M | 52 | 0 | A11A31B14B60Bw6Cw3 | kidney, adrenal gland | BIOCT |
11 R.L. | F | 46 | 1 | A3A29B44Bw4 | lung, liver, soft tissue | CT |
12 G.D. | M | 46 | 0 | A3A28B21B35Cw4 | lymph node | NT |
13 R.G. | M | 65 | 1 | A10B8B38Bw4Bw6Cw7 | lung, soft tissue | BIOCT |
14 T.A. | F | 61 | 1 | A2A19B35B37Bw4Bw6Cw4 | soft tissue | CT+RT |
15 B.A. | F | 59 | 2 | A2A9B39B44Bw4Bw6Cw5 | liver, soft tissue | BIOCT, locoregional CT |
16 C.P. | F | 39 | 0 | A9A19B14B44Bw4Bw6Cw5 | kidney, soft tissue | Locoregional CT |
17 O.M. | M | 56 | 1 | A19A28B5B16Bw4Bw6 | lung, soft tissue | BIOCT |
18 L.B. | F | 39 | 2 | Â | pelvis, lymph node | BIOCT |
19 M.J.L. | F | 37 | 0 | Â | lung, kidney, lymph node, soft tissue | BIOCT |
20 O.G. | M | 65 | 2 | A23A32 | adrenal gland, lymph node, soft tissue | BIOCT |
21 M.R. | F | 38 | 0 | Â | lymph node | BIOCT |
| Â | Â | Â | Â | Â | 21 Viscera: | 13 BIOCT |
|  |  |  |  |  |    - 1 spleen | 3 BIO |
|  |  |  |  |  |    - 5 liver | 4 CT |
|  |  |  |  |  |    - 8 lung | 2 Locoregional CT |
|  |  |  |  |  |    - 3 kidney | 2 RT |
|  |  |  |  |  |    - 2 adrenal gland | 1 NT |
|  |  |  |  |  |    - 2 pelvis |  |
| Â | Â | Â | Â | Â | 2 Bone | Â |
| Â | Â | Â | Â | Â | 8 Lymph node | Â |
| Â | Â | Â | Â | Â | 9 Soft tissue | Â |